New Drugs, Fair Prices addresses the important question of how we might get the innovative new medicines we need at prices we can afford. Today, this debate is impassioned but sterile. One side calls for price controls, discounting their impact on investment in innovation. The other points to miraculous new therapies, disregarding their affordability and social inequity. This polarized argument creates more heat than light, threatening the social contract between the industry and society o...

By any standard, the pharmaceutical industry's history has been a successful one. In addition to its profits and shareholder dividends, it has been seen by investors as relatively low risk and, largely, counter-cyclical to stock market trends. However, that important contribution appears to be petering out, with significant global implications for employees, shareholders, governments and patients. This is not just caused by the economic crisis. Long before this, several distinct but relate...

Written for marketing and finance directors, CEOs, and strategists, as well as MBA students, this practical book explains the principles and practice behind rigorous due diligence in marketing. It connects marketing plans and investment to the valuation of the firm and how it can contribute to increasing stakeholder value. Completely revised and updated throughout, the Second Edition features new case examples as well as a completely new first chapter containing the results of new...

The healthcare professionals who save and extend our lives are helpless without the medicines and technologies that have revolutionised medical care. But the industry that invents, makes and provides these indispensable tools is transforming under the pressure of ageing populations, globalisation and revolutions in biological and information technology. How this industry adapts and evolves is vitally important to every one of us.This book looks inside the heads and hearts of the pe...

Darwin’s Medicine is the sequel to Brian D. Smith’s influential and critically acclaimed Future of Pharma (Gower, 2011). Whereas the earlier book predicted the evolution of the pharmaceutical market and the business models of pharmaceutical companies, Darwin’s Medicine goes much deeper into the drivers of industry change and how leading pharmaceutical and medical technology companies are adapting their strategies, structures and capabilities in practice.T...

"Brian Smith and Paul Raspin demonstrate a thorough and pragmatic approach to creating and applying sound market insight. Using numerous practical examples, learning points and provocative takeaways, they build on established strategic marketing principles to give you actionable knowledge you can apply your business to create lasting market advantage."Beverley Dipper, Market Insight Manager, Microsoft UK Ltd"I have no hesitation in saying buy this book. It will fin...

Strategic Thinking: A Step-by-Step Approach to Strategy and Leadership, now in its third edition, takes you step by step through sound strategic thinking by setting out the questions to ask. In the process of answering these questions and thinking through the important issues that they raise, you will learn how to formulate strategies and write clear and concise strategic plans.With new online material to support each step and help strengthen your ability ...

This upper-level Open Access textbook aims to educate students and professionals on how to develop business models that have a positive impact on people, society, and the social and ecological environment. It explores a different view of how to organize value creation, from a focus on an almost exclusively monetary value creation to one that creates positive impact through multiple values.The book offers students and entrepreneurs a structured approach based through the Business Mo...

The book examines the evolution and current state of corporate social responsibility (CSR), using a five-stage maturity model: defensive, charitable, promotional, strategic and transformative CSR. The first four stages are dubbed CSR 1.0 and characterise most current CSR practice, while the fifth stage is named CSR 2.0 (also transformative or systemic CSR) and describes emergent and future CSR practices. Reasons are given why CSR 1.0 approaches have failed to have any significant impact on...

Have you ever wondered, "What the heck is wrong in our health care systems?"We have made such great progress in medicine, science and overall care. Yet, in many places, we seem to have hit a ceiling of affordability, waste and quality.Do you want to be part of the solution rather than the problem?Have you struggled with how you can possibly contribute?Are you exhausted by the many failed attempts to fix the system?As a re...

Environmental challenges such as pollution, climate change, water and natural resources depletion and dwindling bio-diversity are true threats to the survival of our civilization, forcing us to learn how to act now. Fortunately this is exactly what this book does: presenting real life cases, along with theory, methodologies and tools demonstrating how eco-innovation can support sustainable economic growth and save our planet for future generations.Following an introduction describi...

How can we design circular business models? How can we organize the transition from a linear to a circular economy? And how can we imagine circular futures that help us transform current realities? This book aims to provide answers to these questions while addressing the challenges and opportunities of the circular economy.The authors reflect on why conventional sustainability models – such as the ‘triple P’ (People, Profit and Planet) or eco-efficiency – have failed in addressing ...